A nurse is caring for a patient with active pulmonary tuberculosis who has been on anti-tuberculosis therapy for 6 weeks. The patient reports persistent fatigue, nausea, and yellowing of the eyes. Laboratory results show elevated liver enzymes (ALT 180 U/L, AST 165 U/L). What is the most appropriate nursing intervention?
1Continue current medications and monitor liver enzymes weekly
2Reduce the dosage of all anti-tuberculosis medications by half
3Discontinue isoniazid only and continue other medications
4Hold all anti-tuberculosis medications and notify the physician immediately✓ 정답
해설
The patient shows signs of drug-induced hepatotoxicity (fatigue, nausea, jaundice, elevated ALT/AST) from anti-TB therapy. Immediate intervention is required to prevent liver failure. Other options are inappropriate as they delay treatment or adjust dosages without physician input.
Core Nursing ExplanationKey Concept Analysis: This question assesses the recognition and management of a critical adverse effect: drug-induced hepatotoxicity in a patient undergoing treatment for pulmonary tuberculosis (TB). The standard first-line anti-TB regimen (often including isoniazid, rifampin, pyrazinamide, and ethambutol) is notorious for its potential to cause liver injury. The patient's symptoms (fatigue, nausea, jaundice) and lab values (elevated ALT/AST) are classic signs of this complication. The core nursing principle here is patient safety and the prevention of life-threatening harm.
Answer Rationale: Key Point! The most appropriate action is to Hold all anti-tuberculosis medications and notify the physician immediately. This is the standard, evidence-based protocol when a patient on anti-TB therapy presents with symptoms of hepatitis and significantly elevated liver enzymes. Continuing or arbitrarily adjusting the medication regimen could lead to fulminant liver failure. The nurse's role is to recognize the danger, stop the likely causative agents, and immediately escalate care to the prescribing provider for further evaluation and management (which may include hospitalization, liver function tests, and a revised treatment plan).
Distractor Analysis:
Watch out for confusion! Option ① (Continue current medications and monitor liver enzymes weekly) is dangerously passive. With symptomatic jaundice and enzymes >3-5 times the upper limit of normal, immediate action is required, not just monitoring.
Option ② (Reduce the dosage of all anti-tuberculosis medications by half) is incorrect because dosage adjustment is not within the nurse's independent scope of practice for high-risk medications like these. More importantly, the problem is likely toxicity, not inefficacy, and reducing the dose may not prevent further liver damage.
Option ③ (Discontinue isoniazid only and continue other medications) is a common pitfall. While isoniazid is a frequent culprit, rifampin and pyrazinamide are also hepatotoxic. Discontinuing only one drug is insufficient and assumes the cause, which should be determined by the physician after a full assessment.
Related Concepts: This scenario integrates pharmacology (adverse drug reactions), pathophysiology (hepatocellular injury), and the nursing process (assessment, intervention, collaboration). It also touches on the public health aspect of TB treatment, where treatment interruption must be managed carefully to prevent drug resistance, but patient safety from acute toxicity takes precedence.
Concept Summary
Concept
Key Takeaway
Anti-TB Drug Hepatotoxicity
A major adverse effect of first-line TB drugs (Isoniazid, Rifampin, Pyrazinamide). Presents with fatigue, nausea, anorexia, jaundice, dark urine, elevated LFTs.
Nursing Priority
Recognize signs of liver injury. STOP the medications and NOTIFY the physician immediately. Do not wait or adjust doses independently.
Laboratory Monitoring
Baseline Liver Function Tests (LFTs) are required before starting therapy. Patients should be educated to report symptoms promptly, as routine monitoring may not catch rapid onset.
Patient Education
Teach patients to report any yellowing of skin/eyes, severe fatigue, nausea/vomiting, abdominal pain, or dark urine immediately.
Side-by-Side Comparison!
Action
When It's Appropriate
When It's NOT Appropriate (This Scenario)
Hold meds & notify MD
Suspected severe adverse reaction (anaphylaxis, hepatotoxicity, Stevens-Johnson syndrome). Life-threatening situation.
For minor side effects (mild GI upset, orange discoloration of bodily fluids from rifampin).
Continue & Monitor
Stable patient on long-term therapy with no new symptoms. Part of routine follow-up care.
When patient presents with new, significant symptoms and lab abnormalities indicating organ toxicity.
Adjust Dose Independently
NEVER for anti-TB or other high-risk medications. Dose adjustments are based on pharmacokinetics, efficacy, and toxicity under physician/pharmacist guidance.
Any time a nurse suspects toxicity. This can mask the problem and lead to treatment failure or worsened injury.
Anatomy, Physiology & Pharmacology Points
Liver Enzymes (ALT/AST): Normal ALT is typically 7-56 U/L, Normal AST is 10-40 U/L. Elevations (ALT 180 U/L, AST 165 U/L) indicate hepatocellular damage. ALT is more specific to the liver.
Drug Metabolism: The liver metabolizes many drugs via the cytochrome P450 system. Isoniazid and rifampin can induce this system and produce toxic metabolites that damage liver cells.
Jaundice Pathophysiology: Yellowing of the eyes (scleral icterus) is due to accumulation of bilirubin in the blood, often because the damaged liver cannot conjugate and excrete it properly.
Memory Tips
Acronym "HALT" for Hepatotoxicity: Hold drugs, Assess symptoms/LFTs, Listen to patient (report), Tell (notify) the physician.
Think "Yellow = Stop": Jaundice (yellow skin/eyes) in a patient on hepatotoxic drugs is a red flag to stop the medication and call for help.
First-Line TB Drugs: Mnemonic "RIPE" - Rifampin, Isoniazid, Pyrazinamide, Ethambutol. Remember, the first three (R, I, P) are the most hepatotoxic.
High-Frequency NCLEX Topics
This integrates several high-yield NCLEX areas: medication safety and adverse effects, priority action for a deteriorating patient, collaboration with the healthcare team, and patient education for high-risk medications. NCLEX loves to test your ability to recognize "what requires immediate action" versus "what can be monitored."
Watch Out for Question Variations!
Shift from Symptom to Education: "The nurse is preparing to discharge a patient starting isoniazid therapy. Which instruction is most important?" (Answer: Report yellowing of skin or eyes, severe fatigue, or nausea immediately.)
Shift to Prioritization: "A patient on anti-TB therapy has a temperature of 38°C (100.4°F), mild headache, and orange urine. Which finding should the nurse report immediately?" (Answer: Orange urine is a harmless side effect of rifampin; fever could indicate infection or drug reaction and may need reporting, but it's less urgent than jaundice.)
Shift to Lab Interpretation: "A patient's ALT is 120 U/L after 2 weeks of therapy but is asymptomatic. What is the nurse's best action?" (Answer: This may require closer monitoring and physician notification, but holding all drugs might not be the first step if the patient is asymptomatic. The NCLEX would test the threshold for action.)
Nursing Clinical Practice GuideClinical Scenario: You are the nurse on a medical-surgical unit. Mr. Chen, 58, is being treated for active pulmonary TB with a standard four-drug regimen. During your morning assessment, he says, "I just don't have any energy, and everything I eat makes me feel sick." You note a distinct yellow tinge to his sclerae. You immediately check his most recent lab work and see ALT 180 U/L, AST 165 U/L (drawn yesterday).
Nursing Intervention Strategy:
Immediate Assessment & Action: Document vital signs and a focused assessment (pain in right upper quadrant? dark urine? pale stools?). Then, hold the scheduled morning dose of all anti-TB medications. Do not administer them.
Communication: Notify the attending physician or resident immediately via phone or in person. Use SBAR (Situation, Background, Assessment, Recommendation): "Situation: Mr. Chen, TB patient, shows signs of hepatotoxicity. Background: On RIPE therapy for 6 weeks. Assessment: Complains of fatigue and nausea, has scleral icterus, LFTs are significantly elevated (ALT 180). Recommendation: I have held his morning TB meds. Requesting further orders."
Collaborative Care: Anticipate orders for STAT repeat LFTs, bilirubin, coagulation studies (PT/INR), and possibly an abdominal ultrasound. The physician will decide on discontinuing or modifying the TB regimen. The patient may need hospitalization for monitoring and supportive care (IV fluids, antiemetics).
Patient Education & Support: Explain to the patient and family why the medications are being held ("Your liver is showing signs of stress from the medicine, so we need to let it rest and figure out a safer plan"). Reassure them that this is a known risk and a new treatment plan will be made.
Patient Safety and Precautions:
Never restart anti-TB medications without a specific, written physician order after hepatotoxicity has occurred.
Monitor for signs of worsening liver failure: confusion (hepatic encephalopathy), bruising/bleeding (coagulopathy), ascites.
Remember infection control: The patient with active pulmonary TB must remain in Airborne Precautions (negative pressure room, N95 respirator for staff) until they are no longer infectious, which is typically after several weeks of effective therapy. Hepatotoxicity does not change this isolation requirement.
Nursing Procedure & Medication FlowStep-by-Step for Suspected Hepatotoxicity:
1. Recognize: Link symptoms (jaundice, fatigue, nausea) + lab data (elevated LFTs) to the patient's medication profile.
2. Withhold: Physically remove the medications from the patient's bedside or stop the automated dispensing cabinet (ADC) process.
3. Document: Chart the symptoms, your assessment findings, and the action taken ("0800: Patient c/o fatigue, nausea. Scleral icterus noted. Per protocol for suspected hepatotoxicity, all anti-tuberculosis medications held. Dr. Smith notified.").
4. Monitor: Increase frequency of assessments (vitals, neuro checks, skin/eye color, urine output).
5. Collaborate: Follow up with the physician and pharmacy to understand the new plan of care.
A Word from Your Senior Nurse
"Medication vigilance is a huge part of our job. With powerful drugs like anti-TB therapy, we walk a fine line between treating a deadly infection and protecting the patient from the treatment itself. Your assessment skills are critical here – that moment you look into a patient's eyes and see that hint of yellow could save their liver. On the NCLEX and in real life, when you see a combination of subjective complaints, objective signs (jaundice), and hard data (sky-high LFTs) pointing to a severe adverse reaction, your brain should scream 'STOP THE DRUG, CALL THE DOC.' It's that simple and that important. Trust your nursing judgment!"
Hepatotoxicity — Liver damage caused by chemical agents (like medications). A serious adverse effect of many drugs, including first-line anti-tuberculosis agents.
Isoniazid — A first-line antibiotic for tuberculosis treatment. A common cause of drug-induced hepatitis and peripheral neuropathy.
Alanine Aminotransferase — A liver enzyme found primarily in hepatocytes. Elevated blood levels are a specific marker for hepatocellular injury.
Jaundice/Icterus — Yellow discoloration of the skin, sclerae, and mucous membranes caused by hyperbilirubinemia. A key sign of liver dysfunction or biliary obstruction.
Airborne Precautions — Infection control measures used for patients with diseases transmitted by airborne droplet nuclei (e.g., TB, measles, chickenpox). Requires a negative pressure room and N95 respirator or equivalent for healthcare personnel.